Inventor · disambiguated record
Lev T.D. Fanning
Also filed as: FANNING LEV T D
19 granted patents·8 pending applications·1,420 citations·filing 2009–2021
97Inventor score
Top patents by PatentIndex Score
27 records- 0198US8999976B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2013·Granted Apr 7, 2015·105 cites·22 claims
- 0298US8969382B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2013·Granted Mar 3, 2015·66 cites·10 claims
- 0398US8785640B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2013·Granted Jul 22, 2014·72 cites·35 claims
- 0498US8748612B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2013·Granted Jun 10, 2014·64 cites·13 claims
- 0598US8604203B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2012·Granted Dec 10, 2013·73 cites·35 claims
- 0698US8598205B2Modulators of cystic fibrosis transmembrane conductance regulatorBINCH HAYLEY·Filed 2012·Granted Dec 3, 2013·77 cites·22 claims
- 0798US8552006B2Modulators of cystic fibrosis transmembrane conductance regulatorBINCH HAYLEY·Filed 2010·Granted Oct 8, 2013·74 cites·37 claims
- 0898US8513282B2Modulators of cystic fibrosis transmembrane conductance regulatorBINCH HAYLEY·Filed 2009·Granted Aug 20, 2013·84 cites·11 claims
- 0998US8410132B2Modulators of cystic fibrosis transmembrane conductance regulatorBINCH HAYLEY·Filed 2012·Granted Apr 2, 2013·89 cites·7 claims
- 1098US8314239B2Modulators of cystic fibrosis transmembrane conductance regulatorBINCH HAYLEY·Filed 2009·Granted Nov 20, 2012·100 cites·24 claims
- 1198US8188283B2Modulators of cystic fibrosis transmembrane conductance regulatorBINCH HAYLEY·Filed 2010·Granted May 29, 2012·97 cites·8 claims
- 1297US9051324B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2013·Granted Jun 9, 2015·56 cites·25 claims
- 1397US8614327B2Modulators of ATP-binding cassette transportersVERTEX PHARMA·Filed 2012·Granted Dec 24, 2013·78 cites·9 claims
- 1497US8461352B2Process for preparing azabicyclic compoundsAMBHAIKAR NARENDRA BHALCHANDRA·Filed 2012·Granted Jun 11, 2013·77 cites·1 claims
- 1597US8404865B2Process for preparing azabicyclic compoundsAMBHAIKAR NARENDRA BHALCHANDRA·Filed 2010·Granted Mar 26, 2013·81 cites·20 claims
- 1697US8367660B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2009·Granted Feb 5, 2013·85 cites·17 claims
- 1796US8633189B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2012·Granted Jan 21, 2014·68 cites·24 claims
- 1894US8802700B2Modulators of ATP-Binding Cassette transportersSHETH URVI·Filed 2012·Granted Aug 12, 2014·74 cites·5 claims
- 1962US2014303204A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2014·Application pending·0 cites
- 2054US12502376B2Pyrano[4,3-b]indole derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (AATD)VERTEX PHARMA·Filed 2021·Granted Dec 23, 2025·0 cites·33 claims
- 2154US2014343098A1Modulators of atp-binding cassette transportersVERTEX PHARMA·Filed 2014·Application pending·0 cites
- 2253US2023159502A1Indole derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (aatd)VERTEX PHARMA·Filed 2021·Application pending·0 cites
- 2353US2023339915A1Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 2453US2023159504A17- or 8-hydroxy-isoquinoline and 7- or 8-hydroxy-quinoline derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (aatd)VERTEX PHARMA·Filed 2021·Application pending·0 cites
- 2552US2023159580A1Pyrrolo[2,3-f]indazole and 2,4,5,10-tetrazatricyclo[7.3.0.03,7]dodeca-1,3(7),5,8,11-pentaene derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (aatd)VERTEX PHARMA·Filed 2021·Application pending·0 cites
- 2652US2023159521A11h-pyrazolo[4,3-g]isoquinoline and 1h-pyrazolo[4,3-g]quinoline derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (aatd)VERTEX PHARMA·Filed 2021·Application pending·0 cites
- 2739US2011257223A1Modulators of Cystic Fibrosis Transmembrane Conductance RegulatorVERTEX PHARMA·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lev T.D. Fanning files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →